Child neurology: Recurrent rhabdomyolysis due to a fatty acid oxidation disorder

Neurology

Volumn 82, Issue 1, 2014, Pages

  Terrone, Gaetano ^a   Ruoppolo, Margherita ^a,b   Brunetti Pierri, Nicola ^a   Cozzolino, Carla ^b   Scolamiero, Emanuela ^b   Parenti, Giancarlo ^a   Romano, Alfonso ^a   Andria, Generoso ^a   Salvatore, Francesco ^b,c   Frisso, Giulia ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ACYL COENZYME A DEHYDROGENASE; BICARBONATE; FUROSEMIDE; GLUCOSE; MESSENGER RNA;

ARTICLE; CARBOHYDRATE DIET; CASE REPORT; CHILD; FATTY ACID OXIDATION; HERPETIC STOMATITIS; HETEROZYGOTE; HUMAN; LOW FAT DIET; MALE; MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; NUTRITIONAL DEFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RHABDOMYOLYSIS;

EID: 84892187567     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000438217.31437.72     Document Type: Article

References (10)

1. Mannix R, Tan ML, Wright R, et al. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics 2006;118:2119-2125. (Pubitemid 46393696)
2. Lindner M, Hoffmann GF, Matern D. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis 2010;33:521-526.
3. Yagi M, Lee T, Awano H, et al. A patient with mitochondrial trifunctional protein deficiency due to the mutations in the HADHB gene showed recurrent myalgia since early childhood and was diagnosed in adolescence. Mol Genet Metab 2011;104:556-559.
4. Spiekerkoetter U, Sun B, Khuchua Z, et al. Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to beta-subunit mutations. Hum Mutat 2003;21:598-607. (Pubitemid 36667350)
5. Spiekerkoetter U. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. J Inherit Metab Dis 2010;33:527-532.
6. Sander J, Sander S, Steuerwald U, et al. Neonatal screening for defects of the mitochondrial trifunctional protein. Mol Genet Metab 2005;85:108-114. (Pubitemid 40724535)
7. den Boer ME, Dionisi-Vici C, Chakrapani A, et al. Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr 2003;142:684-689. (Pubitemid 36737173)
8. Fahnehjelm KT, Holmström G, Ying L, et al. Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: across-sectional study with long-term follow-up. Acta Ophthalmol 2008;86: 329-337. (Pubitemid 351790218)
9. Gillingham MB, Scott B, Elliott D, et al. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab 2006;89:58-63. (Pubitemid 44205484)
10. Lamhonwah AM, Olpin SE, Pollitt RJ, et al. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am J Med Genet 2002;111:271-284. (Pubitemid 34815450)